-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

722.O1.6 722. Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Novel Therapies for Graft-versus-Host Disease

Symposia: Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, adult, Acute Myeloid Malignancies, AML, Biological therapies, Lymphoid Leukemias, ALL, clinical trials, Non-Biological therapies, Translational Research, Combination therapy, Clinical Research, pediatric, GVHD, Diseases, Immune Disorders, Therapies, Lymphoid Malignancies, Myeloid Malignancies, Study Population, Human, Transplantation
Monday, December 12, 2022: 10:30 AM-12:00 PM
252-254 (Ernest N. Morial Convention Center)
Moderators:
Dražen Pulanić, MD, PhD, University Hospital Centre Zagreb and Betty K. Hamilton, MD, Cleveland Clinic Foundation
Disclosures:
Hamilton: Equilium: Membership on an entity's Board of Directors or advisory committees; Syndax: Membership on an entity's Board of Directors or advisory committees; Nkarta: Membership on an entity's Board of Directors or advisory committees; Incyte: Membership on an entity's Board of Directors or advisory committees; Kadmon: Membership on an entity's Board of Directors or advisory committees; Mallinkrodt: Speakers Bureau.
This session will focus on novel agents in the treatment of acute and chronic GVHD.
10:30 AM

Amandeep Salhotra, MD1, Samer A Srour, MD, MS2, Rasmus T Hoeg, MD3*, Ayman Saad, MB/BCH4*, Everett H Meyer, MD, PhD5*, Anna Pavlova, MD, PhD6*, Edmund K. Waller, MD, PhD7, Mwe Mwe Chao, MD8*, J Scott McClellan, MD, PhD8, Nathaniel B Fernhoff, PhD8*, Robert Lowsky, MD5 and Mehrdad Abedi, MD9

1Department of Hematology and HCT, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
2Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX
3Department of Internal Medicine, Division of Cellular Therapy, Bone Marrow Transplantation and Malignant Hematology, University of California Davis School of Medicine, Sacramento, CA
4Comprehensive Cancer Center, The Ohio State University, Columbus, OH
5Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA
6Stanford University, Stanford, CA
7Winship Cancer Institute, Emory University, Atlanta, GA
8Orca Bio, Menlo Park, CA
9Davis Comprehensive Cancer Center, University of California, Sacramento, CA

10:45 AM

Alexandra Capellini1*, Aaron Etra, MD1, Amin M Alousi, MD2, Monzr M. Al Malki, MD3, Hannah Choe, MD4, Zachariah Defilipp, MD5, William J. Hogan, MB, BCh6, Carrie Lynn Kitko, MD7, Francis A. Ayuk, MD8*, Janna Baez1*, Isha Gandhi9*, Stelios Kasikis10*, Sigrun Gleich11*, Elizabeth O. Hexner, MD, MSTR12, Matthias Hoepting, MD13*, Urvi Kapoor, MD9*, Steven Kowalyk9*, Deukwoo Kwon, PhD14*, Amelia Langston, MD15, Marco Mielcarek, MD16, George Morales17*, Umut Ozbek, PhD14*, Muna Qayed, MD, MSc18, Ran Reshef, MD19*, Wolf Roesler, M.D.20*, Nikolaos Spyrou, MD9*, Rachel Young9*, Yi-Bin Chen, MD, MS5, James L.M. Ferrara, MD, DSc21 and John E. Levine, MD, MS9

1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
2Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
4Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
5Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA
6Division of Hematology, Mayo Clinic, Rochester, MN
7Pediatric Stem Cell Transplant Program, Vanderbilt University Medical Center, Nashville, TN
8Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
9Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY
10Tisch Cancer Institute, Icahn School of Medicine At Mount Sinai, New York City, NY
11University of Regensburg, Regensburg, DEU
12Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
13Internal Medicine III, University of Regensburg, Regensburg, Germany
14Department of Population Health Science and Policy, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
15Emory University, Winship Cancer Institute, Atlanta, GA
16Adult Blood and Marrow Transplant Program, Fred Hutchinson Cancer Research Center, Seattle, WA
17Tisch Cancer Institute, Icahn School of Medicine At Mount Sinai, New York, NY
18Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
19Columbia University Medical Center, New York, NY
20Med. Klinik III / Poliklinik, Universitätsklinik Erlangen, Erlangen, Germany
21Tisch Cancer Institute, Icahn School of Medicine, New York, NY

11:00 AM

Annie Im, MD1, Daniel Wolff, MD2*, Corey Cutler, MD, MPH3*, Robert Zeiser, MD4, Nirav N. Shah, MD5, Ming Tony Tan, PhD6*, Jaime Sanz, MD7*, Haris Ali, MD8, Giuseppe Milone, MD9, Arjun D. Law, MD10*, Domenico Russo, MD11, Eva-Maria Wagner, MD12*, Olga Ivanova, PhD13*, Kevin Hou, PhD13*, Maureen Bleam, BS13*, Rodica Morariu-Zamfir, MD13* and Steven Z Pavletic, MD, MS14

1Univ. of Pittsburgh Cancer Institute, Pittsburgh, PA
2Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
3Dana-Farber Cancer Institute, Boston, MA
4Department of Medicine I, Medical Center University of Freiburg, Freiburg, Germany
5Medical College of Wisconsin, Brookfield, WI
6Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University Medical Center/Lombardi Comprehensive Cancer Center, Washington, DC
7Avinguda Fernando Abril Martorell, Hospital Universitario La Fe, Valencia, Valencia, Spain
8City of Hope Medical Center, Duarte, CA
9Hematology and BMT Unit, Azienda Ospedaliero Universitaria Policlinico "G.Rodolico-San Marco", Catania, Italy
10University Health Network, Princess Margaret Cancer Centre, Toronto, Canada
11Unit of Blood Diseases and Bone Marrow Transplantation, ASST Spedali Civili, University of Brescia, ASST Spedali Civili, Brescia, Italy
12Haematology and Oncology, University Medical Center, University Medicine Mainz, Mainz, Germany
13Incyte Corporation, Wilmington, DE
14National Cancer Institute, National Institutes of Health, Bethesda, MD

11:15 AM

Haris Ali, MD1, Dongyun Yang, PhD2*, Sally Mokhtari, PhD3, Timothy Synold, PhD4*, Idoroenyi Amanam, MD1, Andrew S. Artz, MD, MS5, Peter T. Curtin, MD1, Karamjeet S. Sandhu, MD1, Anthony S. Stein, MD1*, Shukaib Arslan, MD1, Salman Otoukesh, MD1*, Firoozeh Sahebi, MD6, Joshua Mansour, MD6, Paul B. Koller, MD1, Amandeep Salhotra, MD1, Ibrahim Aldoss, MD1, Vinod A. Pullarkat, MD1*, Brian J Ball, MD7, Stephen J Forman, MD1, Guido Marcucci, MD1, Monzr M. Al Malki, MD1* and Ryotaro Nakamura, MD8*

1Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
2Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
3Department of Clinical Translational Program Development, City of Hope National Medical Center, Duarte, CA
4Department of Cancer Biology, Beckman Research Institute, City of Hope, Duarte, CA
5Department of Hematology/HCT, City of Hope, Duarte, CA
6Department of Hematology/HCT, Southern California Kaiser Permanente, Los Angeles, CA
7Department of Hematology/HCT, City of Hope National Medical Center, Pasadena, CA
8Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA

11:30 AM

Mark A. Schroeder, MD1, Jaebok Choi, PhD1, Himachandana Atluri, MD2, Jordan Atkins, MD3*, Melinda Harding1*, Jeremy Eisele1*, Feng Gao, MD, PhD, MPH4*, Ramzi Abboud, MD1, Camille Abboud Sr., MD5, Amanda F. Cashen, MD6, Matthew Christopher, MD, PhD1*, Todd A. Fehniger, MD, PhD6, Francesca Ferraro, MD, PhD7, Armin Ghobadi, MD1, Meagan A. Jacoby, MD1, Iskra Pusic, MD1, Keith E Stockerl-Goldstein, MD8, Geoffrey L. Uy, MD1, Ravi Vij, MD, MBBS1, Matthew J Walter, MD9, Peter Westervelt, MD, PhD1 and John F. DiPersio, MD, PhD10

1Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
2MD Anderson Cancer Center, Houston, TX
3Division of Hospitalists, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
4Division of Biostatistics, Washington University School of Medicine, Saint Louis, MO
5Division of Oncology, Department of Medicine, Washington University In Saint Louis;, Saint Louis, MO
6Division of Oncology, Washington University School of Medicine, St. Louis, MO
7Department of Medicine, Division of Oncology, Section of Stem Cell Biology, Washington University in St. Louis School of Medicine, SAINT LOUIS, MO
8Department of Medicine, Division of Hematology & Oncology, Washington University School of Medicine, St. Louis, MO
9Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO
10Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO

11:45 AM

Yi-Bin Chen, MD, MS1, Ayman Saad, MD, MSc2*, Shatha Y. Farhan, MD3, Lazaros J. Lekakis, MD4*, Gary J. Schiller, MD5, Jean A. Yared, MD6, Amer Assal, MD7, Dana D Lee, PharmD8*, Hayley Lane9*, Ted A. Gooley, Ph.D.10* and Zachariah Defilipp, MD1

1Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA
2James Cancer Center, Ohio State Medical Center, Columbus, OH
3Henry Ford Hospital, Detroit, MI
4Sylvester Comprehensive Care Center, Division of Transplantation and Cell Therapy, University of Miami Health System, Miami, FL
5David Geffen School of Medicine at UCLA, Los Angeles, CA
6Transplantation & Cellular Therapy Program, Division of Hematology/Oncology, Department of Internal Medicine, University of Maryland Greenebaum Cancer Center, Baltimore, MD
7Blood and Marrow Transplantation Program, Columbia University Medical Center, New York, NY
8Regimmune Corporation, Marina Del Rey
9Regimmune Corporation, Marina Del Rey, CA
10Fred Hutchinson Cancer Center, Seattle, WA

*signifies non-member of ASH